Clinical Trial Update: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating single-fraction real-time high-dose-rate brachytherapy for low- and intermediate-risk prostate cancer; no results are r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Hospital de Cruces | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN